Parkinson Erika, Boyd Pete, Aleksic Maja, Cubberley Richard, O'Connor David, Skipp Paul
Centre for Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK Centre for Proteomic Research, Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK
Centre for Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK Centre for Proteomic Research, Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
Toxicol Sci. 2014 Nov;142(1):239-49. doi: 10.1093/toxsci/kfu168. Epub 2014 Aug 21.
The risk of contact sensitization is a major consideration in the development of new formulations for personal care products. However, developing a mechanistic approach for non-animal risk assessment requires further understanding of haptenation of skin proteins by sensitizing chemicals, which is the molecular initiating event causative of skin sensitization. The non-stoichiometric nature of protein haptenation results in relatively low levels of modification, often of low abundant proteins, presenting a major challenge for their assignment in complex biological matrices such as skin. Instrumental advances over the last few years have led to a considerable increase in sensitivity of mass spectrometry (MS) techniques. We have combined these advancements with a novel dual-labeling/LC-MS(E) approach to provide an in-depth direct comparison of human serum albumin (HSA), 2,4-dinitro-1-chlorobenzene (DNCB), 5-chloro-2-methyl-4-isothiazolin-3-one (MCI), trans-cinnamaldehyde, and 6-methyl coumarin. These data have revealed novel insights into the differences in protein haptenation between sensitizers with different reaction mechanisms and sensitizing potency; the extreme sensitizers DNCB and MCI were shown to modify a greater number of nucleophilic sites than the moderate sensitizer cinnamaldehyde; and the weak/non-sensitizer 6-methyl coumarin was restricted to only a single nucleophilic residue within HSA. The evaluation of this dual labeling/LC-MS(E) approach using HSA as a model protein has also demonstrated that this strategy could be applied to studying global haptenation in complex mixtures of skin-related proteins by different chemicals.
接触致敏风险是个人护理产品新配方开发中的一个主要考虑因素。然而,开发一种用于非动物风险评估的机制方法需要进一步了解致敏化学物质对皮肤蛋白的半抗原化作用,这是皮肤致敏的分子起始事件。蛋白质半抗原化的非化学计量性质导致修饰水平相对较低,且通常修饰的是低丰度蛋白质,这对在诸如皮肤等复杂生物基质中鉴定它们构成了重大挑战。过去几年仪器技术的进步使质谱(MS)技术的灵敏度有了显著提高。我们将这些进展与一种新型的双标记/液相色谱 - 质谱(E)方法相结合,以对人血清白蛋白(HSA)、2,4 - 二硝基 - 1 - 氯苯(DNCB)、5 - 氯 - 2 - 甲基 - 4 - 异噻唑啉 - 3 - 酮(MCI)、反式肉桂醛和6 - 甲基香豆素进行深入的直接比较。这些数据揭示了具有不同反应机制和致敏效力的致敏剂之间蛋白质半抗原化差异的新见解;结果表明,极强致敏剂DNCB和MCI修饰的亲核位点数量比中度致敏剂肉桂醛更多;而弱/非致敏剂6 - 甲基香豆素仅局限于HSA内的单个亲核残基。以HSA作为模型蛋白对这种双标记/液相色谱 - 质谱(E)方法的评估还表明,该策略可应用于研究不同化学物质对皮肤相关蛋白复杂混合物的整体半抗原化作用。